全文获取类型
收费全文 | 19306篇 |
免费 | 1474篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 180篇 |
儿科学 | 720篇 |
妇产科学 | 617篇 |
基础医学 | 2567篇 |
口腔科学 | 221篇 |
临床医学 | 2502篇 |
内科学 | 3364篇 |
皮肤病学 | 301篇 |
神经病学 | 2280篇 |
特种医学 | 371篇 |
外科学 | 1801篇 |
综合类 | 184篇 |
现状与发展 | 1篇 |
一般理论 | 20篇 |
预防医学 | 2810篇 |
眼科学 | 186篇 |
药学 | 1245篇 |
1篇 | |
中国医学 | 15篇 |
肿瘤学 | 1424篇 |
出版年
2024年 | 35篇 |
2023年 | 231篇 |
2022年 | 359篇 |
2021年 | 786篇 |
2020年 | 486篇 |
2019年 | 684篇 |
2018年 | 760篇 |
2017年 | 579篇 |
2016年 | 654篇 |
2015年 | 656篇 |
2014年 | 797篇 |
2013年 | 1220篇 |
2012年 | 1735篇 |
2011年 | 1748篇 |
2010年 | 864篇 |
2009年 | 753篇 |
2008年 | 1175篇 |
2007年 | 1253篇 |
2006年 | 1116篇 |
2005年 | 1017篇 |
2004年 | 947篇 |
2003年 | 803篇 |
2002年 | 766篇 |
2001年 | 110篇 |
2000年 | 79篇 |
1999年 | 102篇 |
1998年 | 137篇 |
1997年 | 111篇 |
1996年 | 75篇 |
1995年 | 75篇 |
1994年 | 54篇 |
1993年 | 49篇 |
1992年 | 47篇 |
1991年 | 32篇 |
1990年 | 25篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 34篇 |
1986年 | 34篇 |
1985年 | 19篇 |
1984年 | 45篇 |
1983年 | 18篇 |
1982年 | 39篇 |
1981年 | 36篇 |
1980年 | 24篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1976年 | 12篇 |
1975年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat. 总被引:3,自引:0,他引:3
Jill H Fowler Katherine Whalley Tracey Murray Michael J O'neill James McCulloch 《Journal of cerebral blood flow and metabolism》2004,24(10):1098-1109
AMPA receptor potentiators enhance AMPA receptor-mediated glutamatergic neurotransmission and may have therapeutic potential as cognitive enhancers or antidepressants. The anatomical basis for the action of AMPA receptor potentiators is unknown. The aim of this study was to determine the effects of the biarylpropylsulfonamide AMPA receptor potentiator, LY404187 (0.05 to 5 mg/kg subcutaneously), upon cerebral glucose utilization and c-fos expression using 14C-2-deoxglucose autoradiography and c-fos immunocytochemistry. LY404187 (0.5 mg/kg) produced significant elevations in glucose utilization in 28 of the 52 anatomical regions analyzed, which included rostral neocortical areas and the hippocampus, as well the dorsal raphe nucleus, lateral habenula, and locus coeruleus. No significant decreases in glucose utilization were observed in any region after LY404187 administration. The increases in glucose utilization with LY404187 (0.5 mg/kg) were blocked by pretreatment with the AMPA receptor antagonist LY293558 (25 mg/kg), indicating that LY404187 acts through AMPA receptor-mediated mechanisms. LY404187 (0.5 mg/kg) also produced increases in c-fos immunoreactivity in the cortex, locus coeruleus, and the dorsal raphe nucleus. These studies demonstrate neuronal activation in key brain areas that are associated with memory processes and thus provide an anatomical basis for the cognitive enhancing effects of AMPA receptor potentiators. 相似文献
32.
33.
34.
Carol E. Golin Katherine Tiller E. Byrd Quinlivan Catherine A. Grodensky Maureen Boland 《AIDS and behavior》2007,11(1):72-83
The epidemiology of HIV infection in the US in general, and in the southeast, in particular, has shifted dramatically over the past two decades, increasingly affecting women and minorities. The site for our intervention was an infectious diseases clinic based at a university hospital serving over 1,300 HIV-infected patients in North Carolina. Our patient population is diverse and reflects the trends seen more broadly in the epidemic in the southeast and in North Carolina. Practicing safer sex is a complex behavior with multiple determinants that vary by individual and social context. A comprehensive intervention that is client-centered and can be tailored to each individual’s circumstances is more likely to be effective at reducing risky behaviors among clients such as ours than are more confrontational or standardized prevention messages. One potential approach to improving safer sex practices among people living with HIV/AIDS (PLWHA) is Motivational Interviewing (MI), a non-judgmental, client-centered but directive counseling style. Below, we describe: (1) the development of the Start Talking About Risks (STAR) MI-based safer sex counseling program for PLWHA at our clinic site; (2) the intervention itself; and (3) lessons learned from implementing the intervention. 相似文献
35.
Dario Giugliano Antonio Ceriello Katherine Esposito 《Journal of the American College of Cardiology》2006,48(4):677-685
Reducing the incidence of coronary heart disease with diet is possible. The main dietary strategies include adequate omega-3 fatty acids intake, reduction of saturated and trans-fats, and consumption of a diet high in fruits, vegetables, nuts, and whole grains and low in refined grains. Each of these strategies may be associated with lower generation of inflammation. This review examines the epidemiologic and clinical evidence concerning diet and inflammation. Dietary patterns high in refined starches, sugar, and saturated and trans-fatty acids, poor in natural antioxidants and fiber from fruits, vegetables, and whole grains, and poor in omega-3 fatty acids may cause an activation of the innate immune system, most likely by an excessive production of proinflammatory cytokines associated with a reduced production of anti-inflammatory cytokines. The whole diet approach seems particularly promising to reduce the inflammation associated with the metabolic syndrome. The choice of healthy sources of carbohydrate, fat, and protein, associated with regular physical activity and avoidance of smoking, is critical to fighting the war against chronic disease. Western dietary patterns warm up inflammation, while prudent dietary patterns cool it down. 相似文献
36.
Paul J Limburg Rachael Z Stolzenberg-Solomon Robert A Vierkant Katherine Roberts Thomas A Sellers Philip R Taylor Jarmo Virtamo James R Cerhan Demetrius Albanes 《Clinical gastroenterology and hepatology》2006,4(12):1514-1521
BACKGROUND & AIMS: Hyperinsulinemia is a putative colorectal cancer (CRC) risk factor. Insulin resistance (IR) commonly precedes hyperinsulinemia and can be quantitatively measured by using the homeostasis model assessment-insulin resistance (HOMA-IR) index. To date, few studies have directly examined serum insulin as an indicator of CRC risk, and none have reported associations on the basis of HOMA-IR. METHODS: We performed a case-cohort study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study (n=29,133). Baseline exposure and fasting serum biomarker data were available for 134 incident CRC case and 399 non-case subjects. HOMA-IR was derived as fasting insulin x fasting glucose/22.5. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated by using age-adjusted and multivariable-adjusted Cox proportional hazards regression models. RESULTS: Median (interquartile range) values for serum insulin, glucose, and HOMA-IR were 4.1 (2.9-7.2) mIU/L, 101 (94-108) mg/dL, and 0.99 (0.69-1.98) for case subjects and 4.1 (2.7-6.1) mIU/L, 99 (93-107) mg/dL, and 1.02 (0.69-1.53) for non-case subjects, respectively. On the basis of comparison of the highest versus lowest quartiles for each biomarker, insulin (HR, 1.84; 95% CI, 1.03-3.30) and HOMA-IR (HR, 1.85; 95% CI, 1.06-3.24) were significantly associated with incident CRC, whereas glucose was marginally associated with incident CRC (HR, 1.70; 95% CI, 0.92-3.13) in age-adjusted risk models. However, trends across biomarker quartiles were somewhat inconsistent (P trend=.12, .04, and .12, respectively), and multivariable adjustment generally attenuated the observed risk estimates. CONCLUSIONS: Data from this prospective study of male smokers provide limited support for hyperinsulinemia, hyperglycemia, and/or insulin resistance as CRC risk factors. 相似文献
37.
Katherine Patterson Corinna Young Steven Paul Woods Ofilio Vigil Igor Grant J. Hampton Atkinson 《International journal of methods in psychiatric research》2006,15(2):75-82
Major Depressive Disorder (MDD) is among the most prevalent but underdiagnosed psychiatric disorders in persons with HIV infection. Given the known adverse impact of comorbid MDD on HIV disease progression and health‐related quality of life, it is important both for research and for efficient, effective clinical care, to validate existing screening measures that may discriminate between MDD and the somatic symptoms of HIV (such as fatigue). In the current study, we evaluated the concurrent predictive validity of the Profile of Mood States (POMS) Depression‐Dejection scale in detecting current MDD in 310 persons with HIV infection. The Structured Clinical Interview for DSM‐IV (SCID) diagnosis of MDD and the Cognitive‐Affective scale from the Beck Depression Inventory (BDI‐CA) served as comparative diagnostic and severity measures of depression, respectively. Results demonstrated that the POMS Depression‐Dejection scale accurately classified persons with and without MDD SCID diagnoses, with an overall hit rate of 80%, sensitivity of 55%, specificity of 84%, and negative predictive power of 91% using a recommended cutpoint of 1.5 standard deviations above the normative mean. Moreover, the POMS performed comparably to the BDI‐CA in classifying MDD. Findings support the predictive validity of the POMS Depression‐Dejection scale as a screening instrument for MDD in persons with HIV disease. Copyright © 2006 John Wiley & Sons, Ltd. 相似文献
38.
Martina Ballmaier Elizabeth R Sowell Paul M Thompson Anand Kumar Katherine L Narr Helen Lavretsky Suzanne E Welcome Heather DeLuca Arthur W Toga 《Neuropsychopharmacology》2004,55(4):382-389
BACKGROUND: In elderly depression, volumetric brain imaging findings suggest abnormalities of the frontal lobe, particularly the orbitofrontal cortex, and the hippocampus. No studies to date have mapped cortical abnormalities over the entire brain surface in major depression. Here, we conducted detailed spatial analyses of brain size and gray matter within the cortical mantle in elderly patients with major depression. METHODS: High-resolution, three-dimensional, structural magnetic resonance imaging data and cortical pattern matching methods were used in 24 depressed elderly patients and 19 group-matched controls to measure local brain size and proportions of gray matter at thousands of homologous cortical surface locations. RESULTS: Prominent brain size reductions were observed in the depressed subjects in the orbitofrontal cortex bilaterally. Cortical gray matter measurements revealed significant gray matter increases in the orbitofrontal cortex, adjacent to focal trend level significant decreases of gray matter in the same region. Depressed patients also exhibited significant gray matter increases in parietal cortices, as well as the left temporal cortex. CONCLUSIONS: Complex cortical changes may contribute to the brain size reduction of the orbitofrontal cortex and to the gray matter abnormalities detected in orbitofrontal cortex and temporoparietal cortices, thereby providing a potentially new window into the pathophysiology of elderly depression. 相似文献
39.
40.
A monoclonal antibody to the molluscan small cardioactive peptide SCPB and a polyclonal antibody to FMRFamide were used to localize antigens in the stomatogastric nervous system and brain of two species of Cancer. Both antibodies labeled cell bodies, axons, and neuropilar processes in the brain and in the stomatogastric nervous system. All of the SCPB immunoreactive neurons were co-labeled with antibody to FMRFamide. However, antibody to FMRFamide labeled additional neurons of the commissural ganglion and the brain that were not immunoreactive to the monoclonal SCPB antibody. 相似文献